Literature DB >> 22293951

Roles of microRNAs and other non-coding RNAs in breast cancer metastasis.

Scott Valastyan1.   

Abstract

Despite the fact that metastases are responsible for the overwhelming majority of human cancer deaths, our comprehension of the molecular events that drive metastatic progression remains woefully incomplete. Excitingly, the recent appreciation that various species of non-coding RNAs—including microRNAs—play pivotal roles in dictating the malignant behaviors of breast carcinoma cells promises to afford new insights into the molecular circuitry that determines metastatic propensity. Here, I summarize our current knowledge regarding these still-emerging functions for non-coding RNAs in the pathogenesis of breast cancer metastasis, with an emphasis placed upon the roles played by microRNAs in these processes. Additionally, I discuss the potential translational opportunities afforded by these research findings for the diagnosis and treatment of human breast tumors. When assessed collectively, it is apparent that although this field of research is still in its infancy, comprehension of the biological actions of microRNAs and other non-coding RNAs will hold important consequences for our understanding of the etiology of metastatic disease, as well as its clinical management and treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293951     DOI: 10.1007/s10911-012-9241-9

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  57 in total

Review 1.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

2.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

3.  LNA-mediated microRNA silencing in non-human primates.

Authors:  Joacim Elmén; Morten Lindow; Sylvia Schütz; Matthew Lawrence; Andreas Petri; Susanna Obad; Marie Lindholm; Maj Hedtjärn; Henrik Frydenlund Hansen; Urs Berger; Steven Gullans; Phil Kearney; Peter Sarnow; Ellen Marie Straarup; Sakari Kauppinen
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

5.  Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.

Authors:  Jason F Wiggins; Lynnsie Ruffino; Kevin Kelnar; Michael Omotola; Lubna Patrawala; David Brown; Andreas G Bader
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

Review 6.  MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell Cycle       Date:  2009-11-13       Impact factor: 4.534

Review 7.  The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis.

Authors:  Manav Korpal; Yibin Kang
Journal:  RNA Biol       Date:  2008 Jul-Sep       Impact factor: 4.652

Review 8.  miR-155: on the crosstalk between inflammation and cancer.

Authors:  Esmerina Tili; Carlo M Croce; Jean-Jacques Michaille
Journal:  Int Rev Immunol       Date:  2009       Impact factor: 5.311

9.  Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Authors:  Manav Korpal; Brian J Ell; Francesca M Buffa; Toni Ibrahim; Mario A Blanco; Toni Celià-Terrassa; Laura Mercatali; Zia Khan; Hani Goodarzi; Yuling Hua; Yong Wei; Guohong Hu; Benjamin A Garcia; Jiannis Ragoussis; Dino Amadori; Adrian L Harris; Yibin Kang
Journal:  Nat Med       Date:  2011-08-07       Impact factor: 53.440

10.  miR-200 enhances mouse breast cancer cell colonization to form distant metastases.

Authors:  Derek M Dykxhoorn; Yichao Wu; Huangming Xie; Fengyan Yu; Ashish Lal; Fabio Petrocca; Denis Martinvalet; Erwei Song; Bing Lim; Judy Lieberman
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more
  13 in total

1.  MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.

Authors:  Lei Huo; Yan Wang; Yun Gong; Savitri Krishnamurthy; Jing Wang; Lixia Diao; Chang-Gong Liu; Xiuping Liu; Feng Lin; William F Symmans; Wei Wei; Xinna Zhang; Li Sun; Ricardo H Alvarez; Naoto T Ueno; Tamer M Fouad; Kenichi Harano; Bisrat G Debeb; Yun Wu; James Reuben; Massimo Cristofanilli; Zhuang Zuo
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

2.  Overexpression of mir-183 and mir-494 promotes proliferation and migration in human breast cancer cell lines.

Authors:  Taciane Macedo; Renato J Silva-Oliveira; Viviane A O Silva; Daniel O Vidal; Adriane F Evangelista; Marcia M C Marques
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

Review 3.  Noncoding RNAs in endocrine malignancy.

Authors:  Jessica Kentwell; Justin S Gundara; Stan B Sidhu
Journal:  Oncologist       Date:  2014-04-09

4.  Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment.

Authors:  Jayoung Kim; Samantha Morley; Minh Le; Denis Bedoret; Dale T Umetsu; Dolores Di Vizio; Michael R Freeman
Journal:  Cancer Biol Ther       Date:  2014-01-14       Impact factor: 4.742

5.  miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.

Authors:  Yan-ming Lu; Chao Shang; Yang-ling Ou; Duo Yin; Yi-ning Li; Xiang Li; Ning Wang; Shu-lan Zhang
Journal:  Med Oncol       Date:  2014-07-23       Impact factor: 3.064

6.  hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3.

Authors:  Jason R Dobson; Hanna Taipaleenmäki; Yu-Jie Hu; Deli Hong; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian; Jitesh Pratap
Journal:  Cancer Cell Int       Date:  2014-08-02       Impact factor: 5.722

7.  MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.

Authors:  Augusto L F Marino; Adriane F Evangelista; René A C Vieira; Taciane Macedo; Ligia M Kerr; Lucas Faria Abrahão-Machado; Adhemar Longatto-Filho; Henrique C S Silveira; Marcia M C Marques
Journal:  BMC Cancer       Date:  2014-10-02       Impact factor: 4.430

8.  STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer.

Authors:  Xiaoman Li; Lufeng Zheng; Feng Zhang; Jinhang Hu; Jinjiang Chou; Yu Liu; Yingying Xing; Tao Xi
Journal:  Oncotarget       Date:  2016-04-26

9.  microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.

Authors:  Jack W Rostas; Hawley C Pruitt; Brandon J Metge; Aparna Mitra; Sarah K Bailey; Sejong Bae; Karan P Singh; Daniel J Devine; Donna L Dyess; William O Richards; J Allan Tucker; Lalita A Shevde; Rajeev S Samant
Journal:  Mol Cancer       Date:  2014-08-29       Impact factor: 27.401

10.  Long-term exposure of MCF-12A normal human breast epithelial cells to ethanol induces epithelial mesenchymal transition and oncogenic features.

Authors:  Robert Gelfand; Dolores Vernet; Kevin Bruhn; Jaydutt Vadgama; Nestor F Gonzalez-Cadavid
Journal:  Int J Oncol       Date:  2016-03-29       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.